Education Library

Prof. Dr. Evgenij V. Potapov discusses combining extracorporeal life support (ECLS) with pMCS for treating advanced cardiogenic shock.

Alaide Chieffo, MD, discusses results from a subanalysis of women in the IMP-IT Registry in Italy.

Are there billable services after Impella® insertion in the cath lab, such as ICU monitoring?

Jacob Abraham, MD, Raymond Lee, MD, and Bindu Akkanti, MD, discuss ECpella therapy in this CAMP webinar moderated by Misty Casseus, MSN, RN.

Learn how to place a mattress suture during explant of the Impella RP® with SmartAssist® in the ICU.

Rohan Goswami, MD, discusses renal recovery in patients with heart failure cardiogenic shock (HFCS) supported with Impella 5.5® with SmartAssist®.

Chuck Simonton, MD, reviews that in October 2022 the FDA accepted and closed all Impella post-approval studies for high-risk PCI, cardiogenic shock, post-cardiotomy cardiogenic shock and right heart failure.

Christopher Lawrance, MD, presents the case of an otherwise healthy 35-year-old woman who requires biventricular Impella support for myocarditis.

Pratik Sandesara, MD, presents a complex case requiring escalation to Impella 5.5® with SmartAssist®.

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.

Vijay Iyer, MD, discusses important concepts being explored in the STEMI-DTU™ trial, emphasizing that unloading is not delaying treatment. 

Jay Giri, MD, discusses the pros, cons, and best uses for five types of observational database analyses.

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock at TCT 2022.